P2.06-20 Bacteria as Novel Anti-Mesothelioma Agents.

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents

English

Anti-Aids Agents 69. Moronic Acid and Other Triterpene Derivatives as Novel Potent Anti-Hiv Agents

English

Lactic Acid Bacteria as Antifungal and Anti-Mycotoxigenic Agents: A Comprehensive Review

Comprehensive Reviews in Food Science and Food Safety
Food Science
2019English

P2.06-19 Targeting Polyamines as Potential Adjuvant Therapy in Malignant Pleural Mesothelioma Xenograft Models

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.06-16 YB-1: An Important Driver of Mesothelioma Drug Resistance and a Potential Novel Therapeutic Target

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.06-15 Malignant Pleural Mesothelioma in Young Adult People in Uganda

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Polyamine Analogues as Novel Anti-Her Family Agents in Human Breast Cancer

2008English

P2.06-42 AXL, C-Met and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Synthesis and Biological Evaluation of Novel Resveratrol-Nsaid Derivatives as Anti-Inflammatory Agents

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy